On 31st January 2025, IPPS will host a launch event exploring the findings of the 4th 100 Days mission Implementation Report, in collaboration with the South African Government and South Africa Medical Research Council.
The report will provide a status update on global efforts to achieving the 100 Days Mission, reflecting on progress made in 2024 amid outbreaks of several diseases of pandemic potential, including the resurgence of mpox, H5N1 and Marburg virus disease.
This event will:
- Publicly launch the fourth 100DM implementation report and 2nd 100 Days Mission scorecard, sharing its key findings and areas for action in 2025;
- Demonstrate examples of African leadership across all aspects of the 100 Days Mission
- Convene partners from all sectors to discuss practical next steps for implementing proposed 2025 priorities.
The event will be hybrid and streamed via Microsoft Teams. Registration is now open for the main plenary convening twice across the day.
| Session Title | Time(s) | Registration Link |
|---|---|---|
Main Plenary
|
|
Register for Plenary |
Full programme
All times in South Africa Standard Time (SAST)
09:00-09:15 – Welcome & Opening Remarks
- Professor Ntobeko Ntusi, President of South Africa MRC
- Minister Motsoaledi, Minister of Health, Government of South Africa (TBC)
- Minister Nzimande, Minister of Science, Technology and Innovation, Government of South Africa
- Dr Mona Nemer, Chair of IPPS & Chief Science Advisor of Canada
09:15-10:00 – Panel 1 – 100 Days Mission 4th Implementation Report Findings
- Moderated by Dr Victor Dzau, IPPS STEG Co-chair & President of the National Academy of Medicine
- Dr Rick A. Bright, Former Director of BARDA USA, IPPS STEG member
- Dr Kelly Chibale, Professor of Organic Chemistry at the University of Cape Town; IPPS STEG member
- Dr Ranna Eardley-Patel, Sustainable Manufacturing Lead at CEPI; IPPS STEG member
- Dr Delese Mimi Darko, Chief Executive at FDA Ghana; IPPS STEG member
10:45-11:45– Panel 2 – African leadership for the 100 Days Mission: From the Political to the Practical
- Moderated by Ms Shingai Machingaidze, IPPS STEG Co-chair & Head of Africa Strategy and Engagement at CEPI
- Prof Jean-Jacques Muyembe, General Director of the National Institute of Biomedical Research
- Dr Mosoka Fallah, Acting Director for the Science and Innovation Directorate at Africa CDC
- Ms Noella Bigirimana, Deputy Director General at Rwanda Biomedical Centre [VIRTUAL]
- Dr Miriam Nanyunja, Senior Risk Management & Preparedness Officer, WHO/EPR Nairobi Hub
- Ms Precious Matsoso, Co-Chair of WHO’s International Negotiating Board (INB) and Director of the Health Regulatory Science Platform at the University of Witwatersrand in South Africa
11:45-12:45 – Panel 3 – Strengthening Public Private Partnerships to facilitate synergies across DTVs
- Moderated by Dr Michelle Mulder, Executive Director of the Grants, Innovation and Product Development, South Africa MRC
- Professor Mario Moreira, President of Fiocruz; IPPS Steering Group Member
- Professor Petro Terblanche, CEO at Afrigen Biologics
- Mr Bada Pharasi, CEO Innovative Pharmaceutical Association South Africa
-
Dr Boitumelo Semete-Makokotlela, CEO at South African Health Products Regulatory Authority (SAHPRA)
BREAK FOR LUNCH
13:45-15:00 – Parallel Workshops – by invitation only
Workshop A: Building R&D ecosystems for PPR
- Led by Dr Mongezi Mdhuli, Chief Research Operation Officer, SAMRC and Co-Chair, GloPID-R
- Ms Glaudina Loots, Director for Health Innovation at the Department of Science and Innovation, Government of South Africa
- Dr Thomas Kariuki, Executive Director of Science for Africa Foundation
- Dr Jane Knisley, Senior Program Officer for Special Projects, Division of Microbiology and Infectious Disease, DHHS/NIH/NIAID
- Professor Mario Moreira, President of Fiocruz; IPPS Steering Group Member
Workshop B: What is needed to elevate AI & Biosecurity for the 100 Days Mission?
- Led by Dr Beth Cameron, Professor of the Practice and Senior Advisor to the Pandemic Center at the Brown University School of Public Health
- Dr Lynda Stuart, Executive Director of the Institute for Protein Design at the University of Washington School of Medicine; IPPS STEG Member
- Dr Kelly Chibale, IPPS STEG member, Professor of Organic Chemistry at the University of Cape Town, South Africa
- Mr Nqobile Ndlovu CEO African Society for Laboratory Medicine
- Dr Bilal Mateen, Chief AI Officer at PATH
15.15 – 16.00 – Plenary: Promising advances in therapeutics development
Chairs:
- Ms Shingai Machingaidze, IPPS STEG Co-chair & Head of Africa Strategy and Engagement at CEPI
- Dr Victor Dzau, IPPS STEG Co-chair & President of the National Academy of Medicine
Speakers:
- Mr Owen Mulenga, Treatment Advocacy and Literacy Campaign (TALC) in Zambia
- Ms Lynette Keneilwe Mabote-Eyde, AIDS and Rights Alliance for Southern Africa; former Unitaid NGO board member
- Dr Anban Pillay, Deputy Director General at the National Department of Health, Government of South Africa
16.00 – 16.15 – Summary Remarks
- Dr Mona Nemer, Chair of IPPS & Chief Science Advisor of Canada
For general enquiries about the event, contact IPPS: info@ippsecretariat.org
For media enquiries, please contact Ashley Giles, Senior Strategic Engagement Adviser: a.giles@ippsecretariat.org